This inventor holds 1 USPTO granted patent. Top assignee: Hongyun Biotech Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yachuang Wu: Innovator in Alkenyl Pyrimidine Compounds
Introduction
Yachuang Wu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Yachuang Wu holds a patent for an alkenyl pyrimidine compound, which includes a preparation method and its applications. This invention relates to a compound that exhibits EGFR inhibitory activity, along with its pharmaceutically acceptable salts and solvates. The patent outlines a preparation method for this compound, a pharmaceutical composition containing it, and its use in developing drugs aimed at preventing and treating cancer and other diseases mediated by EGFR kinase. He has 1 patent to his name.
Career Highlights
Wu is associated with Hongyun Biotech Co., Ltd., where he applies his expertise in medicinal chemistry and drug development. His work focuses on creating innovative solutions for complex health issues, particularly in oncology.
Collaborations
Yachuang Wu collaborates with notable colleagues, including Xianming Deng and Wei Huang, to advance research and development in their field.
Conclusion
Yachuang Wu's contributions to the development of alkenyl pyrimidine compounds highlight his role as an innovator in the pharmaceutical industry. His work continues to pave the way for new treatments in cancer therapy and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile